Investment and M&A transaction comps
Healthcare Investment & M&A Transaction Comps
Healthcare services, healthcare IT, medtech, diagnostics, life sciences tools and related healthcare transactions. Pure biotech rows are tracked separately where normal revenue multiples are less meaningful.
8
Reviewed transactions
2
With price data
-
Median EV or valuation / revenue
11.0x
Median EV or valuation / EBITDA
| Year | Transactions | Priced | Median EV or valuation / revenue | Median EV or valuation / EBITDA |
|---|---|---|---|---|
| 2026 | 4 | 1 | - | - |
Sortable transaction comps
Healthcare transaction table
Rows with reported value
2 / 8
Acquisition value, USD
USD 3.2B
Investment capital, USD
-
Median EV or valuation / revenue
-
Select up to 12 rows across filters and pages, then share or export the set.
Selected comparison set
Saved in this browser only. Nothing is written to FundComb data.
Choose transactions from the table to build a quick comparison set.
8 shown of 8 matching transactions. Click any transaction row for more detail.
| Select for comparison | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| BIO-CAT Enzymes & Microbials Control | 2026-07-31 | Lallemand Inc. | Undisclosed | Undisclosed | - | - | United States | Confirmed 1 source | ||
| Avanos Medical, Inc. Control | 2026-07-27 | American Industrial Partners | Undisclosed | Undisclosed | - | - | United States | Confirmed 1 source | ||
| 2026-07-13 | Servier | Undisclosed | Undisclosed | - | - | - | Confirmed 2 sources | |||
| 2026-07-06 | Altaris LLC | USD 600M Consideration | 600 | - | - | - | Confirmed 1 source | |||
| Flexion Therapeutics Control | 2021-10-11 | Pacira BioSciences | Undisclosed | Undisclosed | - | 11.0x | United States | Confirmed 1 source | ||
| Aimmune Therapeutics Control | 2020-08-31 | Sociétés des Produits Nestlé S.A. / Nestlé Health Science | USD 2.6B | 2,600 | - | - | United States | Estimated 1 source | ||
| E-Pharma Trento Control (100%) | - | Wise Equity | Undisclosed | Undisclosed | - | - | Italy | Confirmed 1 source | ||
| Cross Country Healthcare Control | - | Knox Lane | Undisclosed | Undisclosed | - | - | - | Confirmed 1 source |
FundComb transaction comps are informational only. Prices are shown as estimated enterprise value where available, with USD used as the default sorting currency; revenue and EBITDA multiples are shown where available. Values may be estimated, rumored, incomplete or derived from public information and should not be relied upon as financial, investment or valuation advice.